Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10187)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2015 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chang E, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol 2015; 21(25): 7754-7763 [PMID: 26167075 DOI: 10.3748/wjg.v21.i25.7754] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7754.htm |
| Number | Citing Articles |
| 1 |
Atcharaporn Ontawong, Acharaporn Duangjai, Chatchai Muanprasat, Tipthida Pasachan, Anchalee Pongchaidecha, Doungporn Amornlerdpison, Chutima Srimaroeng. Lipid-lowering effects of Coffea arabica pulp aqueous extract in Caco-2 cells and hypercholesterolemic rats. Phytomedicine 2019; 52: 187 doi: 10.1016/j.phymed.2018.06.021
|
| 2 |
Kevser Taban Akça, İlknur Çınar Ayan, Sümeyra Çetinkaya, Ece Miser Salihoğlu, İpek Süntar. Autophagic mechanisms in longevity intervention: role of natural active compounds. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.5
|
| 3 |
Miguel Vázquez-Velasco, Laura González-Torres, Rosa A. García-Fernández, María Teresa Méndez, Sara Bastida, Juana Benedí, María José González-Muñoz, Francisco J. Sánchez-Muniz. Glucomannan or Glucomannan Plus Spirulina-Enriched Squid-Surimi Diets Reduce Histological Damage to Liver and Heart in Zucker fa/fa Rats Fed a Cholesterol-Enriched and Non-Cholesterol-Enriched Atherogenic Diet. Journal of Medicinal Food 2017; 20(6): 618 doi: 10.1089/jmf.2016.0157
|
| 4 |
Jaehyun Bae, Namki Hong, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee. Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis. Journal of Clinical Medicine 2020; 9(3): 798 doi: 10.3390/jcm9030798
|
| 5 |
Gouda K. Helal, Magdy A. Gad, Mohamed F. Abd-Ellah, Elsayed M. Mahgoup. Coadministration of ezetimibe with pegylated interferon plus ribavirin could improve early virological response in chronic hepatitis C obese Egyptian patients. European Journal of Gastroenterology & Hepatology 2016; 28(5): 553 doi: 10.1097/MEG.0000000000000587
|
| 6 |
Hyekyung Yang, Dong Ho Suh, Eun Sung Jung, Yoonjin Lee, Kwang-Hyeon Liu, In-Gu Do, Choong Hwan Lee, Cheol-Young Park. Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1406493
|
| 7 |
Ji Yong Kim, David Mondaca-Ruff, Sandeep Singh, Yu Wang. SIRT1 and Autophagy: Implications in Endocrine Disorders. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.930919
|
| 8 |
Jung Bok Lee, Jeong Su Park, Young Min Shin, Da Hyun Lee, Jeong‐Kee Yoon, Dae‐Hyun Kim, Ung Hyun Ko, YongTae Kim, Soo Han Bae, Hak‐Joon Sung. Implantable Vascularized Liver Chip for Cross‐Validation of Disease Treatment with Animal Model. Advanced Functional Materials 2019; 29(23) doi: 10.1002/adfm.201900075
|
| 9 |
Jianjian Zhao, Lei Peng, Ruibing Cui, Xiaolan Guo, Ming Yan. Dimethyl α-ketoglutarate reduces CCl4-induced liver fibrosis through inhibition of autophagy in hepatic stellate cells. Biochemical and Biophysical Research Communications 2016; 481(1-2): 90 doi: 10.1016/j.bbrc.2016.11.010
|
| 10 |
Fengming Xu, Chuanfeng Hua, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen. The Role of Autophagy for the Regeneration of the Aging Liver. International Journal of Molecular Sciences 2020; 21(10): 3606 doi: 10.3390/ijms21103606
|
| 11 |
Yingmei Zhang, James R. Sowers, Jun Ren. Targeting autophagy in obesity: from pathophysiology to management. Nature Reviews Endocrinology 2018; 14(6): 356 doi: 10.1038/s41574-018-0009-1
|
| 12 |
Hyekyung Yang, Dong Ho Suh, Dae Hee Kim, Eun Sung Jung, Kwang‐Hyeon Liu, Choong Hwan Lee, Cheol‐Young Park. Metabolomic and lipidomic analysis of the effect of pioglitazone on hepatic steatosis in a rat model of obese Type 2 diabetes. British Journal of Pharmacology 2018; 175(17): 3610 doi: 10.1111/bph.14434
|
| 13 |
Fatemeh Heydarpour, Soraya Sajadimajd, Elahe Mirzarazi, Pouya Haratipour, Tanuj Joshi, Mohammad Hosein Farzaei, Haroon Khan, Javier Echeverría. Involvement of TGF-β and Autophagy Pathways in Pathogenesis of Diabetes: A Comprehensive Review on Biological and Pharmacological Insights. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.498758
|
| 14 |
Silvia Ezquerro, Gema Frühbeck, Amaia Rodríguez. Ghrelin and autophagy. Current Opinion in Clinical Nutrition & Metabolic Care 2017; 20(5): 402 doi: 10.1097/MCO.0000000000000390
|
| 15 |
Carlota Tuero, Sara Becerril, Silvia Ezquerro, Gabriela Neira, Gema Frühbeck, Amaia Rodríguez. Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression. Journal of Physiology and Biochemistry 2023; 79(4): 833 doi: 10.1007/s13105-022-00933-1
|
| 16 |
Mar Quiñones, Johan Fernø, Omar Al-Massadi. Ghrelin and liver disease. Reviews in Endocrine and Metabolic Disorders 2020; 21(1): 45 doi: 10.1007/s11154-019-09528-6
|
| 17 |
Yingmei Zhang, Adam T. Whaley-Connell, James R. Sowers, Jun Ren. Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management. Pharmacology & Therapeutics 2018; 191: 1 doi: 10.1016/j.pharmthera.2018.06.004
|
| 18 |
Youngmi Song, Hyekyung Yang, Juhee Kim, Yoonjin Lee, Sung-Ho Kim, In-Gu Do, Cheol-Young Park. Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy. Molecular Metabolism 2023; 78: 101806 doi: 10.1016/j.molmet.2023.101806
|
| 19 |
Da Hyun Lee, Dai Hoon Han, Ki Taek Nam, Jeong Su Park, Soo Hyun Kim, Milim Lee, Gyuri Kim, Byung Soh Min, Bong-Soo Cha, Yu Seol Lee, Su Haeng Sung, Haengdueng Jeong, Hye Won Ji, Moon Joo Lee, Jae Sung Lee, Hui-Young Lee, Yoomi Chun, Joungmok Kim, Masaaki Komatsu, Yong-ho Lee, Soo Han Bae. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2016; 99: 520 doi: 10.1016/j.freeradbiomed.2016.09.009
|
| 20 |
Eugene Chang, Dae-Hee Kim, Hyekyung Yang, Da Hyun Lee, Soo Han Bae, Cheol-Young Park, Pavel Strnad. CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. PLOS ONE 2018; 13(10): e0206152 doi: 10.1371/journal.pone.0206152
|
| 21 |
Ying Tan, Yan Gong, Maolong Dong, Zhaohui Pei, Jun Ren. Role of autophagy in inherited metabolic and endocrine myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(1): 48 doi: 10.1016/j.bbadis.2018.10.023
|
| 22 |
Silvia Ezquerro, Leire Méndez-Giménez, Sara Becerril, Rafael Moncada, Víctor Valentí, Victoria Catalán, Javier Gómez-Ambrosi, Gema Frühbeck, Amaia Rodríguez. Acylated and desacyl ghrelin are associated with hepatic lipogenesis, β-oxidation and autophagy: role in NAFLD amelioration after sleeve gastrectomy in obese rats. Scientific Reports 2016; 6(1) doi: 10.1038/srep39942
|
| 23 |
Katherine Byrnes, Sophia Blessinger, Niani Tiaye Bailey, Russell Scaife, Gang Liu, Bilon Khambu. Therapeutic regulation of autophagy in hepatic metabolism. Acta Pharmaceutica Sinica B 2022; 12(1): 33 doi: 10.1016/j.apsb.2021.07.021
|
| 24 |
Eugene Chang. 1,25-Dihydroxyvitamin D Decreases Tertiary Butyl-Hydrogen Peroxide-Induced Oxidative Stress and Increases AMPK/SIRT1 Activation in C2C12 Muscle Cells. Molecules 2019; 24(21): 3903 doi: 10.3390/molecules24213903
|
| 25 |
Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos. Is there a role of lipid-lowering therapies in the management of fatty liver disease?. World Journal of Hepatology 2022; 14(1): 119-139 doi: 10.4254/wjh.v14.i1.119
|
| 26 |
Chong Zhao, Yuhan Fu, Xuan Ma, Shuang Zhao, Han Zhang, Shutao Yin, Hongbo Hu. Autophagy-Based Intervention Strategy in the Management of Hepatotoxicity. Antioxidants & Redox Signaling 2023; 38(16-18): 1082 doi: 10.1089/ars.2022.0051
|
| 27 |
Ryoko Shimada, Miho Fujita, Masahiro Yuasa, Hiromi Sawamura, Toshiaki Watanabe, Ayaka Nakashima, Kengo Suzuki. Oral administration of green algae, Euglena gracilis, inhibits hyperglycemia in OLETF rats, a model of spontaneous type 2 diabetes. Food & Function 2016; 7(11): 4655 doi: 10.1039/C6FO00606J
|
| 28 |
Mingyue Gao, Wei Zhao, Chunmei Li, Xianghong Xie, Meixia Li, Yalan Bi, Fude Fang, Yunfeng Du, Xiaojun Liu. Spermidine ameliorates non-alcoholic fatty liver disease through regulating lipid metabolism via AMPK. Biochemical and Biophysical Research Communications 2018; 505(1): 93 doi: 10.1016/j.bbrc.2018.09.078
|
| 29 |
Ching-Chih Chang, Hui-Chun Huang, Shao-Jung Hsu, Chon-Kit Pun, Chiao-Lin Chuang, Ming-Chih Hou, Fa-Yauh Lee. Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats. Journal of the Chinese Medical Association 2024; 87(5): 463 doi: 10.1097/JCMA.0000000000001075
|